CVS Health Corp vs iShares 1 3 Year Treasury Bond ETF — how do they compare? CVS Health Corp trades at $86.3 (market cap $112.49B), while iShares 1 3 Year Treasury Bond ETF trades at $82.96 (market cap $26.63B). The key difference: CVS Health Corp is far larger — about 4.2× iShares 1 3 Year Treasury Bond ETF's market cap, and CVS Health Corp pays a 3.02% dividend while iShares 1 3 Year Treasury Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and iShares 1 3 Year Treasury Bond ETF for 63 Days on average.
| CVS | SHY | |
|---|---|---|
Market Cap | $112.49B | $26.63B |
Volume | 8,467,392 | 4,081,431 |
Sector | Health | Fixed Income |
52-Week High | $110.60 | $83.18 |
52-Week Low | $70.08 | $81.05 |
Typical Hold Time | 83 Days | 63 Days |
Enterprise Value | $174.83B | — |
Dividend Yield | 3.02% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
SHY is trading at $81.16 with minimal daily movement (+0.04%), showing stability amid broader bond market volatility. The technical picture remains bearish with moving averages signaling downward pressure, while oscillators suggest neutral momentum. Recent corporate actions include consistent dividend payments, with the latest being $0.24 per share. The fund operates in a challenging interest rate environment where short-term bond ETFs face both opportunities and headwinds from Federal Reserve policy shifts.
The outlook for SHY is mixed, with potential benefits from rising short-term yields but significant pressure from the ongoing bond market selloff. Investment opportunities include exposure to increasing interest rates with limited duration risk, while risks encompass continued bond market volatility and macroeconomic uncertainty driving yields higher. The fund's stability and dividend consistency provide some defensive characteristics in turbulent markets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →